Amniotic membrane transplantation in the surgical management of symblepharon following toxic epidermal necrolysis [1]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 2, 2006, Pages 214-216

  Atzori, L ^a   Peiretti, E ^a   Ferreli, C ^a   Pinna, A L ^a   Fossarello, M ^a   Aste, N ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HYALURONIC ACID; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PENICILLIN G; STREPTOMYCIN; ANTIHYPERTENSIVE AGENT;

AGED; AMNION; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG MEGADOSE; ERYTHEMA; EYE MOVEMENT; FACE EDEMA; FEMALE; FEVER; HUMAN; LABORATORY DIAGNOSIS; LETTER; POSTOPERATIVE CARE; PRIORITY JOURNAL; SKIN BIOPSY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYMBLEPHARON; TISSUE TRANSPLANTATION; TOXIC EPIDERMAL NECROLYSIS; DIFFERENTIAL DIAGNOSIS; EYE SURGERY; EYELID DISEASE; PATHOLOGY; TRANSPLANTATION;

AGED; AMNION; ANTIHYPERTENSIVE AGENTS; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL NECROLYSIS, TOXIC; EYELID DISEASES; FEMALE; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES;

EID: 33646229104     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01360.x     Document Type: Letter

References (18)

1. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23: 1039-1058.
2. Sane SP, Bhatt AD. Stevens-Johnson syndrome and toxic epidermal necrolysis. Challenge of recognition and management. JAPI 2000; 48: 999-1003.
3. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD 95 with human intravenous immunoglobulin. Science 1998; 282: 490-493.
4. Garcia-Doval I, Le Cleach L, Bocquet H et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol 2000; 136: 323-327.
5. Power WJ, Ghoraishi M, Merayo-Lloves J et al. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/Toxic epidermal necrolysis disease spectrum. Ophthalmology 1995; 102: 1669-1676.
6. Solomon A, Espana EM, Tseng SC. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 2003; 110: 93-100.
7. Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996; 122: 38-52.
8. Tseng SCG, Phabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997; 124: 764-774.
9. John T, Foulks GN, John ME, Cheng K, Hu D. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophtalmology 2002; 109: 351-360.
10. Errani A, Reggiani M, Schianchi S, Staffa M. Toxic epidermal necrolysis induced by barbiturates and radiotherapy. Br J Dermatol 1994; 131: 586-587.
11. Litt JZ. Pocketbook of Drug Eruptions and Interactions. The Parthenon Publishing Group Inc., New York, 1999.
12. Thestrup-Pedersen K. Adverse reactions in the skin from antihypertensive drugs. Dan Med Bull 1987; 34: 3-5.
13. Steckelings UM, Artuc M, Wollschlager T, Wiehstutz S, Henz BM. Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol 2001; 81: 321-325.
14. Gambini D, Sala F, Gianotti R, Cusini M. Exanthematous reaction to irbesartan. JEADV 2003; 17: 472-473.
15. Pierard Franchimont C, Henry F, Pierard GE. Vasculite pustuleuse severe et polymorphe induite par le losartan. Ann Dermatol Venereol 2001; 128: 1040-1042.
16. Touraud JP, Louguet C, Collet E et al. Toxidermie aux sartans. Reaction croisée avec les inhibiteurs de l'enzyme de conversion. Ann Dermatol Venereol 2000; 127: 83.
17. Koizumi N, Inatomi T, Sotozono C et al. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 2000; 20: 173-177.
18. Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea 1999; 18: 73-79.